These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21060034)
1. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both? Einhorn LH; Abonour R; Kesler KA J Clin Oncol; 2010 Dec; 28(35):e739; author reply e740. PubMed ID: 21060034 [No Abstract] [Full Text] [Related]
2. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer. Margolin KA; Doroshow JH; Frankel P; Chow W; Leong LA; Lim D; McNamara M; Morgan RJ; Shibata S; Somlo G; Twardowski P; Yen Y; Kogut N; Schriber J; Alvarnas J; Stalter S Biol Blood Marrow Transplant; 2005 Nov; 11(11):903-11. PubMed ID: 16275593 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. Kondagunta GV; Bacik J; Sheinfeld J; Bajorin D; Bains M; Reich L; Deluca J; Budnick A; Ishill N; Mazumdar M; Bosl GJ; Motzer RJ J Clin Oncol; 2007 Jan; 25(1):85-90. PubMed ID: 17194908 [TBL] [Abstract][Full Text] [Related]
4. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience. Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179 [TBL] [Abstract][Full Text] [Related]
6. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. Rick O; Bokemeyer C; Beyer J; Hartmann JT; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll HJ; Derigs G; Gerl A; Berdel WE; Kanz L; Siegert W J Clin Oncol; 2001 Jan; 19(1):81-8. PubMed ID: 11134198 [TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920 [TBL] [Abstract][Full Text] [Related]
10. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372 [TBL] [Abstract][Full Text] [Related]
11. High dose chemotherapy in germ cell tumors. Rosti G; De Giorgi U Tunis Med; 2005 Dec; 83 Suppl 12():85-6. PubMed ID: 16430076 [No Abstract] [Full Text] [Related]
12. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin. Siegert W; Rick O; Beyer J Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622 [No Abstract] [Full Text] [Related]
13. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors. Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors. Kuwano H; Tsuchiya T; Murayama T; Sano A; Nagayama K; Yoshida Y; Murakawa T; Nakajima J Surg Today; 2014 Mar; 44(3):499-504. PubMed ID: 23553421 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study. Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649 [TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience. Richardson NH; Taza F; Abonour R; Althouse SK; Ashkar R; Abu Zaid M; Hanna NH; Kesler KA; Adra N; Einhorn LH Cancer; 2024 Sep; 130(18):3115-3122. PubMed ID: 38768296 [TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
20. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]